💨 Abstract
In its second quarter of 2025, VolitionRX Ltd. reported a loss of $6.3 million, or 6 cents per share. The Henderson, Nevada-based life sciences company generated $406,700 in revenue and $407,000 in adjusted revenue during this period. The story was created by Automated Insights using data from Zacks Investment Research.
Courtesy: WTOP Staff
Suggested
EE.UU. y Europa siguen haciendo negocios por miles de millones de dólares con Rusia a pesar de años de guerra -
Temporary barriers spared Alaska’s capital from severe flooding. A long-term solution is elusive -
Love’s absence, Colts QB battle are feature attractions of joint practice with Packers -
Drive Shack: Q2 Earnings Snapshot -
Delaware ex-Gov. Mike Castle, who championed 50 State Quarters Program while in Congress, dies at 86 -
Maye and McCarthy show progress in Patriots-Vikings joint practices -
Louisiana sues Roblox alleging the popular gaming site fails to protect children -
Tomoyuki Sugano earns 10th victory as Orioles outlast Mariners 5-3 after long rain delay -
Raiders’ Ashton Jeanty shows big-play ability in joint practice with the 49ers -
Oramed: Q2 Earnings Snapshot -